Athena Diagnostics, Inc.
Records under this name other than the patents Athena Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Back to Athena Diagnostics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,273,701 | Compositions and methods for genetic analysis of polycystic kidney disease Term ended Term ended Nov 8, 2023 · From the USPTO record | Term ended | Term ended Nov 8, 2023 | From the USPTO record |
| US 7,119,186 | Application of Aprataxin Gene to Diagnosis and Treatment for Early-Onset Spinocerebellar Ataxia (EAOH) Term ended Term ended Apr 22, 2023 · High confidence | Term ended | Term ended Apr 22, 2023 | High confidence |
| US 6,916,619 | Compositions and Methods for Genetic Analysis of Polycystic Kidney Disease Term ended Term ended Mar 10, 2023 · High confidence | Term ended | Term ended Mar 10, 2023 | High confidence |
| US 7,824,860 | Application of Aprataxin Gene to Diagnosis and Treatment for Early-Onset Spinocerebellar Ataxia (EAOH) Lapsed on the fee record Ended Nov 2, 2022 · High confidence | Lapsed on the fee record | Ended Nov 2, 2022 | High confidence |
| US 7,521,190 | Compositions and methods for genetic analysis of polycystic kidney disease Lapsed on the fee record Ended Apr 21, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 21, 2021 | From the USPTO record |
| US 6,599,756 | Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups Term ended Ended no later than Jul 27, 2020 · From the USPTO record | Term ended | Ended no later than Jul 27, 2020 | From the USPTO record |
| US 6,951,763 | Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups Term ended Term ended Jul 27, 2020 · From the USPTO record | Term ended | Term ended Jul 27, 2020 | From the USPTO record |
| US 6,824,999 | Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups Term ended Term ended May 5, 2020 · From the USPTO record | Term ended | Term ended May 5, 2020 | From the USPTO record |
| US 6,485,960 | Polycystic kidney disease 1 gene and uses thereof Term ended Term ended Nov 26, 2019 · From the USPTO record | Term ended | Term ended Nov 26, 2019 | From the USPTO record |
| US 7,799,529 | Nephrin gene and protein Lapsed on the fee record Ended Sep 21, 2018 · From the USPTO record | Lapsed on the fee record | Ended Sep 21, 2018 | From the USPTO record |